Skip to main content

Animations

MJFF Publications

7261 - 7270 of 8808 Results
Title
Year
  • Year
  • 2018
  • 2020
  • 2018
  • 2018
  • 2025
  • 2022
  • 2021
  • 2021
  • 2020
  • 2021
  • Summary Details
    OPEN
    Title: 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.018
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Protection from α-Synuclein induced dopaminergic neurodegeneration by overexpression of the mitochondrial import receptor TOM20
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-020-00139-6
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease
    Journal Name: PROTEOMICS
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/pmic.201800108
    Citation Count: 66
  • Summary Details
    OPEN
    Title: Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-018-0848-7
    Citation Count: 107
  • Summary Details
    OPEN
    Title: Novel regulators of heparan sulfate proteoglycans modulate cellular uptake of α-synuclein fibrils
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-025-08786-2
    Citation Count: 0
  • Summary Details
    OPEN
    Title: NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome Activation
    Journal Name: International Journal of Inflammation
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2022/2337363
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Reconstitution of cargo-induced LC3 lipidation in mammalian selective autophagy
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.abg4922
    Citation Count: 43
  • Summary Details
    OPEN
    Title: The potential of biomaterials for central nervous system cellular repair
    Journal Name: Neurochemistry International
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuint.2021.104971
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Analysis of Heterozygous PRKN Variants and Copy‐Number Variations in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28299
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Prefrontal Physiomarkers of Anxiety and Depression in Parkinson’s Disease
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2021.748165
    Citation Count: 20
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.